Quent Capital LLC Increases Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Quent Capital LLC boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 21.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 780 shares of the company’s stock after acquiring an additional 137 shares during the quarter. Quent Capital LLC’s holdings in GE HealthCare Technologies were worth $71,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of GEHC. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after buying an additional 5,693,244 shares in the last quarter. Norges Bank purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $229,052,000. Capital Research Global Investors increased its position in shares of GE HealthCare Technologies by 2.8% in the fourth quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock valued at $3,969,975,000 after buying an additional 1,401,566 shares in the last quarter. Perpetual Ltd purchased a new stake in shares of GE HealthCare Technologies in the first quarter valued at approximately $96,135,000. Finally, Stonegate Investment Group LLC increased its position in shares of GE HealthCare Technologies by 3,555.0% in the fourth quarter. Stonegate Investment Group LLC now owns 654,391 shares of the company’s stock valued at $50,598,000 after buying an additional 636,487 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $76.35 on Tuesday. The stock’s fifty day moving average is $78.69 and its two-hundred day moving average is $81.90. The firm has a market capitalization of $34.85 billion, a P/E ratio of 22.32, a price-to-earnings-growth ratio of 2.77 and a beta of 1.20. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same quarter in the previous year, the company posted $0.85 earnings per share. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Insider Activity

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, with a total value of $100,623.80. Following the purchase, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the business’s stock in a transaction on Wednesday, May 1st. The shares were bought at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the purchase, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jan Makela sold 20,227 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $81.57, for a total transaction of $1,649,916.39. Following the completion of the transaction, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The disclosure for this sale can be found here. Insiders have sold a total of 90,482 shares of company stock valued at $7,369,137 in the last quarter. Insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on GEHC. Evercore ISI boosted their price objective on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Bank of America cut their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. The Goldman Sachs Group started coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target for the company. Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Finally, Mizuho dropped their price target on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.09.

Check Out Our Latest Report on GE HealthCare Technologies

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Recommended Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.